| RS144995033 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 28, TRIOBP-related disorder |
| RS144995231 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1449954533 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1449962580 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1449966934 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS144996870 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144996877 |
ALOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1449972974 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1449980834 |
CYP4F22
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 5, Autosomal recessive congenital ichthyosis 5 |
| RS144998416 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Acute febrile neutrophilic dermatosis |
| RS144999144 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144999773 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS1449998297 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS1449999247 |
TUBGCP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pachygyria, microcephaly |
| RS1450008394 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS145000912 |
GYG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145001056 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS145001300 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Inborn genetic diseases |
| RS145002269 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS145002466 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
VDR-related disorder, VDR-related disorder |
| RS145003411 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS1450037999 |
PROC
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS145003921 |
COL10A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal chondrodysplasia, Schmid type |
| RS145004106 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1450044732 |
LZTR1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1450045618 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS1450046707 |
MALT1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Uterine corpus endometrial carcinoma |
| RS1450052915 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS145005596 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Inborn genetic diseases |
| RS145006217 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, autosomal dominant 71 |
| RS145006535 |
SLC35A1
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC35A1-congenital disorder of glycosylation, SLC35A1-related disorder |
| RS145007061 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS145007501 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Oligodontia-cancer predisposition syndrome |
| RS145007645 |
ACD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 6 |
| RS145007686 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS145008882 |
DNAAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 10, Primary ciliary dyskinesia |
| RS145009013 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Long QT syndrome 3 |
| RS1450090350 |
DPAGT1
|
Health Risk |
Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, DPAGT1-congenital disorder of glycosylation |
| RS145009419 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1450097151 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1450097579 |
HYAL1
|
Health Risk |
Pathogenic |
Deficiency of hyaluronoglucosaminidase, Deficiency of hyaluronoglucosaminidase |
| RS145010538 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1V, Alzheimer disease 4 |
| RS1450111961 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS145012001 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1450121966 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Inborn genetic diseases |
| RS1450125094 |
ABCA1
|
Health Risk |
Likely pathogenic |
Early-onset coronary artery disease, Early-onset coronary artery disease |
| RS145012943 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1450133957 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS145013523 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS145013633 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS145014649 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1450151864 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS145015653 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Acute febrile neutrophilic dermatosis |
| RS145015947 |
RANBP17
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145016043 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1450163641 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Inborn genetic diseases |
| RS145017164 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1D |
| RS1450177088 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS1450178339 |
TG
|
Health Risk |
Pathogenic |
— |
| RS145018253 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS145018323 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS145018385 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1450189213 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1450189463 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1450190162 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS1450190654 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS145019640 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, OTOF-related disorder |
| RS145019788 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Idiopathic hypereosinophilic syndrome |
| RS145020225 |
WNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2B, Inborn genetic diseases |
| RS145020363 |
IL6ST
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145021638 |
LPIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoglobinuria, acute recurrent |
| RS145021738 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1450218521 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1450223894 |
PYCR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS1450225029 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Inborn genetic diseases |
| RS145022945 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS145023130 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS1450238352 |
XPC
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group C |
| RS145023922 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1450240396 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS145024832 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS145025745 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1450257625 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS145026721 |
GJA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 14 multiple types, Inborn genetic diseases |
| RS145027663 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1450277471 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1450281991 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS145028315 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1450284892 |
PUS1
|
Health Risk |
Likely pathogenic |
— |
| RS145028869 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145029382 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1450294572 |
PIKFYVE
|
Health Risk |
Likely pathogenic |
PIKFYVE-related disorder, PIKFYVE-related disorder |
| RS1450297382 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS145029761 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitreoretinopathy, Wagner disease |
| RS145029982 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, SLC34A3-related disorder |
| RS1450302081 |
CA2
|
Health Risk |
Likely pathogenic |
CA2-related disorder, CA2-related disorder |
| RS1450310137 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1450314617 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS145031583 |
AFF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Inborn genetic diseases |
| RS145031656 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |